Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities

NEXT STORY
Revive To Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
PREV STORY
Advaxis Reports Second Quarter Ended April 30, 2021 Financial Results and Provides a Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Triphase Accelerator Reports Completion of Initial Regulatory Interactions with FDA and Health Canada for TRPH-222 for the Treatment of Lymphoma

TORONTO and SAN DIEGO, May 01, 2017 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a ...

author_avatar
NASDAQ Market News

GeoVax Comments on Age-Associated HIV Infection Trends in the U.S.

ATLANTA, GA, Sept. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - GeoVax Labs, Inc. ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: EHVA starts recruiting participants to clinical trial testing FIT Biotech’s vaccine

FIT Biotech Oy Company release 27.11.2018 at 03:00 PM EET EHVA starts recruiting participants to ...

author_avatar
NASDAQ Market News